LB Pharmaceuticals Quarterly Balance Sheet
NASDAQ: LBRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
LB Pharmaceuticals financial position
As of Jun 30, 2026, LB Pharmaceuticals reported total assets of $361.7 million against total liabilities of $29.3 million. Shareholders' equity stood at $332.3 million, or 91.9% of assets. The company held $283.1 million in cash and equivalents.
The current ratio (current assets divided by current liabilities) was 15.08, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
LB Pharmaceuticals balance sheet (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 283.11M | 320.68M | 250.17M | 269.74M | — | — | 22.98M | — | — | — |
| Short-Term Investments | 44.68M | 44.96M | 45.04M | 44.73M | — | — | 5.02M | — | — | — |
| Total Current Assets | 355.30M | 389.07M | 308.43M | 316.40M | — | — | 28.88M | — | — | — |
| Property, Plant & Equipment | 2.20M | 1.53M | 1.58M | 1.64M | — | — | 1.86M | — | — | — |
| Total Assets | 361.69M | 393.48M | 312.93M | 320.75M | — | — | 33.53M | — | — | — |
| Accounts Payable | 3.49M | 7.12M | 2.13M | 2.59M | — | — | 2.32M | — | — | — |
| Total Current Liabilities | 23.56M | 10.91M | 7.44M | 6.65M | — | — | 8.11M | — | — | — |
| Total Liabilities | 29.34M | 14.79M | 11.62M | 10.53M | — | — | 13.83M | — | — | — |
| Shareholders' Equity | 332.35M | 378.69M | 301.31M | 310.22M | -103.87M | -99.34M | -94.55M | -91.45M | -77.44M | -50.45M |
| Retained Earnings | -200.19M | -148.58M | -129.53M | -118.06M | — | — | -104.32M | — | — | — |
| Net Cash (Debt) | 327.79M | 365.64M | 295.21M | 314.48M | — | — | 28.00M | — | — | — |
| Shares Outstanding | 28.68M | 28.67M | 25.30M | 25.30M | — | — | 251.66K | — | — | — |
This table shows 10 quarterly periods of LB Pharmaceuticals's balance sheet, from Q2 2026 back to Q1 2024, across 12 line items including cash & equivalents, short-term investments, total current assets. Values in USD; B = billions, M = millions. Fiscal periods follow LBRX's reporting calendar. What is a balance sheet?